Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001130319-07-000236
Filing Date
2007-03-28
Accepted
2007-03-28 11:41:34
Documents
8
Period of Report
2006-12-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-K o35253e10vk.htm 10-K 933185
2 SUMMARY OF ANNUAL COMPENSATION o35253exv10w28.htm EX-10.28 6123
3 CONSENT OF DELOITTE & TOUCHE LLP o35253exv23w1.htm EX-23.1 1822
4 CERTIFICATION PURSUANT TO SECTION 302 o35253exv31w1.htm EX-31.1 8843
5 CERTIFICATION PURSUANT TO SECTION 302 o35253exv31w2.htm EX-31.2 9314
6 CERTIFICATION PURSUANT TO 18 U.S.C. SECTION 1350 o35253exv32w1.htm EX-32.1 3230
7 CERTIFICATION PURSUANT TO 18 U.S.C. SECTION 1350 o35253exv32w2.htm EX-32.2 3267
8 GRAPHIC o35253o3525301.gif GRAPHIC 4156
  Complete submission text file 0001130319-07-000236.txt   973104
Mailing Address 50 AUDUBON ROAD SUITE B WAKEFIELD MA 01880
Business Address 50 AUDUBON ROAD SUITE B WAKEFIELD MA 01880 781-224-1444
NUCRYST Pharmaceuticals Corp. (Filer) CIK: 0001344674 (see all company filings)

EIN.: 000000000 | State of Incorp.: A0 | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 000-51686 | Film No.: 07723185
SIC: 3841 Surgical & Medical Instruments & Apparatus